{
  "chapter_title": "Financials",
  "section_title": "Share Price",
  "description": "Market valuation and stock performance (if publicly listed).",
  "questions": [
    {
      "question": "What is the current market valuation of Ion Beam Applications SA, and how does it compare to its peers in the industry?",
      "queries": [
        {
          "query": "Ion Beam Applications SA market capitalization",
          "results": [
            {
              "text": "company \nincorporated and domiciled in Belgium. The \naddress of its registered office is Chemin du \nCyclotron, 3; B-1348 \nLouvain-la-Neuve, Belgium. Ion Beam Applications SA is the \nmother Company of the Group and the Ultimate \nParent. The Company is listed on the pan-European \nEuronext stock exchange (B-compartment) and \nis included in the BEL Mid Index. IBA publishes condensed half-yearly and \nannual consolidated financial statements which \nhave been prepared in accordance with IFRS \nas endorsed by EU.",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "Ion Beam Applications SA stock price comparison with industry peers",
          "results": [
            {
              "text": "company \nincorporated and domiciled in Belgium. The \naddress of its registered office is Chemin du \nCyclotron, 3; B-1348 \nLouvain-la-Neuve, Belgium. Ion Beam Applications SA is the \nmother Company of the Group and the Ultimate \nParent. The Company is listed on the pan-European \nEuronext stock exchange (B-compartment) and \nis included in the BEL Mid Index. IBA publishes condensed half-yearly and \nannual consolidated financial statements which \nhave been prepared in accordance with IFRS \nas endorsed by EU.",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "Market value of Ion Beam Applications SA",
          "results": [
            {
              "text": "00% \n100% \nIon Beam Beijing Applications Co. Ltd. Beijing, China \n100% \n100% \nIBA RadioIsotopes France SAS \nLyon, France \n100% \n100% \nIBA Dosimetry Ltd. Schwarzenbruck, Germany \n100% \n100% \nIBA Dosimetry America Inc. Bartlett, USA \n100% \n100% \nIBA Proton Therapy Inc. Edgewood New York, USA \n100% \n100% \nIBA Industrial Inc. Edgewood New York, USA \n100% \n100% \nIBA USA Inc. Edgewood New York, USA \n100% \n100% \nIBA Particle Therapy Ltd.",
              "source": "",
              "score": 0.0
            }
          ]
        }
      ]
    },
    {
      "question": "What are the key drivers behind the fluctuations in Ion Beam Applications SA's share price over the past 12 months?",
      "queries": [
        {
          "query": "Reasons for fluctuation in Ion Beam Applications SA stock price",
          "results": [
            {
              "text": "ions \ndiffer greatly from one country to another. Operational risks \nSale risk \nIn general, IBAs customers are diversified \n(public and private sector) and located on \nseveral continents. Each year the Company \ndepends on multiple orders, particularly for its \nproton therapy systems that are implemented \nover several financial years. One additional \norder or one order less, or changes in an order \nthat were not anticipated at the beginning of the \nyear, are characteristics of this field of business \nthat can have a significant impact over several \naccounting periods.",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "Key factors affecting Ion Beam Applications SA share price",
          "results": [
            {
              "text": "STATUTORY AUDITOR'S REPORT TO THE GENERAL SHAREHOLDERS MEETING OF ION \nBEAM APPLICATION SA ON THE CONSOLIDATED ACCOUNTS FOR THE YEAR ENDED \n31 DECEMBER 2023",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "Stock performance analysis of Ion Beam Applications SA",
          "results": [
            {
              "text": "company \nincorporated and domiciled in Belgium. The \naddress of its registered office is Chemin du \nCyclotron, 3; B-1348 \nLouvain-la-Neuve, Belgium. Ion Beam Applications SA is the \nmother Company of the Group and the Ultimate \nParent. The Company is listed on the pan-European \nEuronext stock exchange (B-compartment) and \nis included in the BEL Mid Index. IBA publishes condensed half-yearly and \nannual consolidated financial statements which \nhave been prepared in accordance with IFRS \nas endorsed by EU.",
              "source": "",
              "score": 0.0
            }
          ]
        }
      ]
    },
    {
      "question": "What is the company's history with dividend payments, and what does this suggest about its financial health?",
      "queries": [
        {
          "query": "Ion Beam Applications SA dividend payment history",
          "results": [
            {
              "text": "The consolidated accounts of Ion Beam Application SA for the fiscal year ended on December 31, 2022, have been audited by another auditor who expressed an unqualified opinion on these \nconsolidated accounts in their report dated April 28, 2023. Responsibilities of the board of directors for the preparation of the consolidated accounts",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "Dividend payout ratio of Ion Beam Applications SA",
          "results": [
            {
              "text": "00% \n100% \nIon Beam Beijing Applications Co. Ltd. Beijing, China \n100% \n100% \nIBA RadioIsotopes France SAS \nLyon, France \n100% \n100% \nIBA Dosimetry Ltd. Schwarzenbruck, Germany \n100% \n100% \nIBA Dosimetry America Inc. Bartlett, USA \n100% \n100% \nIBA Proton Therapy Inc. Edgewood New York, USA \n100% \n100% \nIBA Industrial Inc. Edgewood New York, USA \n100% \n100% \nIBA USA Inc. Edgewood New York, USA \n100% \n100% \nIBA Particle Therapy Ltd.",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "Financial stability indicators for Ion Beam Applications SA",
          "results": [
            {
              "text": "The consolidated accounts of Ion Beam Application SA for the fiscal year ended on December 31, 2022, have been audited by another auditor who expressed an unqualified opinion on these \nconsolidated accounts in their report dated April 28, 2023. Responsibilities of the board of directors for the preparation of the consolidated accounts",
              "source": "",
              "score": 0.0
            }
          ]
        }
      ]
    },
    {
      "question": "How has the company's share price performed during periods of economic uncertainty, such as recessions or market downturns?",
      "queries": [
        {
          "query": "Ion Beam Applications SA stock performance during economic downturns",
          "results": [
            {
              "text": "company \nincorporated and domiciled in Belgium. The \naddress of its registered office is Chemin du \nCyclotron, 3; B-1348 \nLouvain-la-Neuve, Belgium. Ion Beam Applications SA is the \nmother Company of the Group and the Ultimate \nParent. The Company is listed on the pan-European \nEuronext stock exchange (B-compartment) and \nis included in the BEL Mid Index. IBA publishes condensed half-yearly and \nannual consolidated financial statements which \nhave been prepared in accordance with IFRS \nas endorsed by EU.",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "Share price resilience of Ion Beam Applications SA during recession",
          "results": [
            {
              "text": "STATUTORY AUDITOR'S REPORT TO THE GENERAL SHAREHOLDERS MEETING OF ION \nBEAM APPLICATION SA ON THE CONSOLIDATED ACCOUNTS FOR THE YEAR ENDED \n31 DECEMBER 2023",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "Company stock price stability analysis",
          "results": [
            {
              "text": "The Company used the Black & Scholes model to value options, with no vesting conditions other than time. Expected \nvolatility for the stock option plans is based on historical volatility determined by statistical analysis of daily share price \nmovements. The exercise price of shares for the stock option plans was based on the average share price for the 30 days \npreceding the grant date. === Page 165 ===\nIBA Annual Report 2023 \n162. (EUR 000) \nFINANCIAL LIABILITIES \nDecember 31, 2022 \nDue \n< 1 y",
              "source": "",
              "score": 0.0
            }
          ]
        }
      ]
    },
    {
      "question": "What are the most significant risks and challenges facing Ion Beam Applications SA's share price in the near future?",
      "queries": [
        {
          "query": "Risks to Ion Beam Applications SA share price",
          "results": [
            {
              "text": "company \nincorporated and domiciled in Belgium. The \naddress of its registered office is Chemin du \nCyclotron, 3; B-1348 \nLouvain-la-Neuve, Belgium. Ion Beam Applications SA is the \nmother Company of the Group and the Ultimate \nParent. The Company is listed on the pan-European \nEuronext stock exchange (B-compartment) and \nis included in the BEL Mid Index. IBA publishes condensed half-yearly and \nannual consolidated financial statements which \nhave been prepared in accordance with IFRS \nas endorsed by EU.",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "Challenges facing Ion Beam Applications SA stock performance",
          "results": [
            {
              "text": "company \nincorporated and domiciled in Belgium. The \naddress of its registered office is Chemin du \nCyclotron, 3; B-1348 \nLouvain-la-Neuve, Belgium. Ion Beam Applications SA is the \nmother Company of the Group and the Ultimate \nParent. The Company is listed on the pan-European \nEuronext stock exchange (B-compartment) and \nis included in the BEL Mid Index. IBA publishes condensed half-yearly and \nannual consolidated financial statements which \nhave been prepared in accordance with IFRS \nas endorsed by EU.",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "Company stock price forecasting",
          "results": [
            {
              "text": "The Company used the Black & Scholes model to value options, with no vesting conditions other than time. Expected \nvolatility for the stock option plans is based on historical volatility determined by statistical analysis of daily share price \nmovements. The exercise price of shares for the stock option plans was based on the average share price for the 30 days \npreceding the grant date. === Page 165 ===\nIBA Annual Report 2023 \n162. (EUR 000) \nFINANCIAL LIABILITIES \nDecember 31, 2022 \nDue \n< 1 y",
              "source": "",
              "score": 0.0
            }
          ]
        }
      ]
    }
  ]
}